These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1967720)

  • 21. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
    Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on infarct size and left ventricular function of early intravenous injection of anistreplase in acute myocardial infarction. The APSIM Study Investigators.
    Bassand JP; Bernard Y; Lusson JR; Machecourt J; Cassagnes J; Borel E
    Clin Cardiol; 1990 Mar; Suppl 5():V39-44; discussion V67-72. PubMed ID: 2182240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
    Anderson JL
    Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction.
    Karagounis L; Sorensen SG; Menlove RL; Moreno F; Anderson JL
    J Am Coll Cardiol; 1992 Jan; 19(1):1-10. PubMed ID: 1729317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction.
    Meinertz T; Kasper W; Schumacher M; Just H
    Am J Cardiol; 1988 Sep; 62(7):347-51. PubMed ID: 3046283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
    Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
    Karagounis L; Moreno F; Menlove RL; Ipsen S; Anderson JL
    Am J Cardiol; 1991 Oct; 68(9):848-56. PubMed ID: 1927942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
    Jackson D
    Drugs; 1987; 33 Suppl 3():104-11. PubMed ID: 3315574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
    Baxter-Jones CS; White HD; Anderson JL
    J Interv Cardiol; 1993 Mar; 6(1):15-23. PubMed ID: 10171637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J
    Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anistreplase: a novel thrombolytic agent for acute myocardial infarction.
    Marinac JS; North DS; Stringer KA
    DICP; 1990 Jun; 24(6):607-15. PubMed ID: 2193460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive reperfusion study. II. Multicentre European randomized trial of anistreplase vs streptokinase in acute myocardial infarction.
    Pacouret G; Charbonnier B; Curien ND; Monassier JP; Cribier A; Materne P; Brochier ML; Letac R; Hanssen M; Sacrez A
    Eur Heart J; 1991 Feb; 12(2):179-85. PubMed ID: 2044551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous fibrinolytic therapy of acute myocardial infarction: new perspectives from plasminogen activators?
    Kasper W; Meinertz T; Just H
    Klin Wochenschr; 1986 Apr; 64(7):301-6. PubMed ID: 3086619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis.
    Barbagelata NA; Granger CB; Oqueli E; Suárez LD; Borruel M; Topol EJ; Califf RM
    Am Heart J; 1997 Mar; 133(3):273-82. PubMed ID: 9060794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours.
    Machecourt J; Dumoulin J; Calop J; Foroni L; Terisse MP; Henon T; Vanzetto G; Denis B; Bassand JP; Cassagnes J
    Eur Heart J; 1993 Jan; 14(1):75-83. PubMed ID: 8432296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.